Yohei Doi, MD, PhD, has been promoted to the rank of Professor of Medicine with tenure, effective February 1, 2021. Dr. Doi joined the Division of Infectious Diseases as an ID Fellow in 2005. Following fellowship, he joined the ID Division at the rank of Assistant Professor of Medicine. He was promoted to the rank of Associate Professor of Medicine in 2016. Dr. Doi began a joint appointment with Fujita Health University in Aichi, Japan in 2017, where he serves as Professor and Chair of the Department of Microbiology. Dr. Doi received conferral of tenure with the University of Pittsburgh in 2018.
Dr. Doi is internationally recognized for his work in and knowledge of the mechanisms of antimicrobial resistance in Gram-negative pathogens. Serving in the role of Director for the Center for Innovative Antimicrobial Therapy (CIAT), Dr. Doi is responsible for the development and oversight of the Center based in the ID Division. The major goal of the CIAT is to investigate and identify antimicrobial resistance of clinical concern among gram-negative bacterial pathogens. The Center’s areas of research include the genetic and molecular basis of emerging antimicrobial resistance mechanisms; the rapid diagnosis of resistance utilizing phenotypic, genetic and lipidomic approaches; and, inhibitor-based drug discovery. Under Dr. Doi’s leadership, the Center is developing long-term solutions to the antimicrobial resistance crisis. The Center also serves as a platform to assemble and grow a cadre of faculty with relevant expertise, giving rise to collaborative research programs that will advance the field. CIAT’s areas of priority are led by faculty from the Division of Infectious Diseases and other collaborating departments within the School of Medicine.
Dr. Doi is a creative, gifted, and accomplished investigator, and a dedicated clinician, teacher and research mentor. He utilizes his expertise in genetics, genomics, and protein chemistry to elucidate emerging mechanisms of antimicrobial resistance of Gram-negative pathogens to generate important data and devise new clinical and translational studies towards improving diagnostic, preventive and treatment strategies for antimicrobial-resistant bacteria. Dr. Doi is highly respected as an expert in the field of antimicrobial resistance. He has a remarkable record of achievement as a funded scientist, collaborator, and mentor. He is an outstanding role model for students, residents, fellows, and junior faculty. Dr. Doi was honored with an Editorship appointment for Antimicrobial Agents and Chemotherapy (AAC), the top journal on antimicrobial agents, published by the American Society for Microbiology, which he served for 5 years. He has also been serving as Chair of the Gram-Negative Committee of the NIH-funded Antibacterial Resistance Leadership Group since 2015. Dr. Doi continues to distinguish himself as a leading scientist in the field of infectious diseases and he will continue to enrich the academic environment at the University of Pittsburgh.
Please join us in congratulating, Yohei!